
	Ms. Paula J. Conroy served as Chief Financial Officer and Secretary of Altair Nanotechnologies, Inc. since September 26, 2013 until January 13, 2014. Ms. Conroy has been Chief Financial Officer and Vice President at American Institute of Toxicology, Inc., since 2012. She oversees the accounting, finance and risk management functions for AIT. She has been the Managing Member of Blue Bar Consulting, LLC since 2010. She served as Senior Managing Consultant of BKD LLP from 2008 to 2010, and Chief Financial Officer of RCS Management Corporation from 2007 to 2008. Prior to joining AIT, she owned and operated a consulting business specializing in Chief Financial Officer services to privately held companies. She served as the Senior Vice President and Chief Financial Officer of Windrose Medical Properties Trust from January 30, 2006 to 2007 and served as its Principal Accounting Officer. Ms. Conroy served as the Director of Finance and Corporate Accounts Operations at Roche Diagnostics Corp. from 2002 to 2006. She began her career with Ernst &amp; Young LLP in 1983 and held several positions until her resignation in 2002. Ms. Conroy spent for twenty years at Ernst &amp; Young, LLP, as National Director of Employee Benefit Plan Services. She was responsible for mergers and acquisitions, due diligence, and auditing in both the public and private sectors. She lectures at Purdue University. She is a Certified Public Accountant. She has a Masters Diploma in Business Administration from Purdue University and a Bachelor of Science Diploma in General Management with an Accounting option from Purdue University.
